IP Library Granted Patent US 8,309,350
Granted Patent B2
US 8,309,350 · App. 13/364,105 · Granted Nov 13, 2012

Photoreactive regulator of protein function and methods of use thereof

Assignee: The Regents of the University of California
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,309,350
App. No.
13/364,105
Granted
Nov 13, 2012
Kind
B2
Abstract

The present invention provides a synthetic regulator of protein function, which regulator is a light-sensitive regulator. The present invention further provides a light-regulated polypeptide that includes a subject synthetic regulator. Also provided are cells and membranes comprising a subject light-regulated polypeptide. The present invention further provides methods of modulating protein function, involving use of light. The present invention further provides methods of identifying agents that modulate protein function.

Claims (13)

1. A cell comprising a light-regulated polypeptide, wherein the light-regulated polypeptide comprises an ionotropic glutamate receptor (iGluR) and a synthetic regulator of said iGluR, wherein the synthetic regulator has the structure:

wherein R 1 is a binding moiety that provides for covalent linkage to the iGluR, wherein R 1 is selected from the group consisting of a maleimide, an acrylic ester, an acrylic amide, acrylamide, an α-haloacetamide, an epoxide, a succinimidyl ester, a disulfide, vinylsulfone, and a methanethiosulfonate; and R 2 has the structure:

wherein n is 0, 1 or 2; m is 1 or 3; and R″ is a ligand of the iGluR, and wherein the synthetic regulator is stably associated with the iGluR at or near a ligand binding site of the iGluR.

2. The cell of claim 1 , wherein cell is a mammalian cell.

3. The cell of claim 2 , wherein the mammalian cell is a cell line.

4. The cell of claim 3 , wherein the mammalian cell is selected from a 293 cell, a 3T3 cell, a COS cell, and a PC12 cell.

5. The cell of claim 1 , wherein R 1 is selected from —NHCOCH 2 -maleimide, —NHCOCH═CH 2 , and —NHCOCH 2 —X wherein X is a halogen; and

R″ is a glutamate.

6. The cell of claim 5 , wherein R″ is a glutamate.

7. The cell of claim 1 , wherein the synthetic regulator has the structure:

8. The cell of claim 1 , wherein the synthetic regulator has the structure:

9. A method of modulating ligand binding to a ligand binding site of the light-regulated polypeptide present in the cell of claim 1 , the method comprising changing the wavelength of light and/or the intensity of light to which the light-regulated polypeptide in the cell is exposed.

10. The method of claim 9 , wherein said change in wavelength results in an increased probability of binding of the ligand to the ligand-binding site of the light-regulated polypeptide.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 29, 2012
From: ISACOFF, EHUD Y.; KRAMER, RICHARD H.; TRAUNER, DIRK; BANGHART, MATTHEW R.; VOLGRAF, MATTHEW; GOROSTIZA LANGA, PABLO IGNACIO; BORGES, KATHARINE
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 028472/0351 →
Continuity (3)
Division 11601591 · Nov 17, 2006
Provisional Application 60737935 · Nov 18, 2005
Related Publication 20120190094A1 · Jul 26, 2012